fDi Markets Newswire:

Julia Santos

Johnson & Johnson takes outsourcing route to business growth

Julia Santos, head of global business optimisation for the Johnson & Johnson Group, explains to Barbara Njau why outsourcing is essential to the company’s business strategy.

Belarus biotech TEASER

Belarus grasps pharmaceutical initiative

The pharmaceutical market in Belarus is seen as one of the country's most promising areas for economic growth, and with two pharma producers among its most profitable state-owned enterprises, this is a fact not lost on foreign investors.

medichem

Time up for Medichem's Maltese haven?

Medichem has grown its Malta business out of the country’s patent-free status for drugs. But with Malta's entrance into the EU and changing legislation, the clock is ticking for the pharmaceuticals company

Wallonia's reinvention

The Wallonia region in Belgium has remarketed itself to attract new partners and investor companies, and is carving a niche as a hub for pharmaceuticals and life sciences investment

Big pharma gets bigger

The trend for amalgamation within the pharmaceutical sector is creating ever bigger and stronger companies, writes Lara Williams.

An eye on expansion

The global of president Bausch & Lomb’s pharmaceutical division tells Lara Williams how the company’s global presence has helped it defy the economic slowdown, and that it now has Asia-Pacific, eastern Europe and Latin America in its sights.

fDi Tools

fDi Intelligence has a portfolio of related products that enable you to get the targeted foreign investment information you need for your role: 

fdimarkets

For real-time crossborder greenfield investment data on all sectors and locations, click here

fdibenchmark

To benchmark locations for investment projects, click here

fdireports

For bespoke reports on companies, locations or sectors, click here